$136.93
-6.25[-4.37%]
At close: Apr 25
$136.93
0[0.00%]
After Hours: 4:00PM EDT
Ascendis Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ascendis Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | ASND | Q1 | -$2.13 | — | — | — | $36.05M | — | — | — | Get Alert |
02/07/2024 | PM | ASND | Q4 | -$3.78 | -$2.15 | -$1.66 | 22.79% | $23.37M | $97.02M | $148.22M | 52.77% | Get Alert |
11/07/2023 | PM | ASND | Q3 | -$3.05 | -$2.75 | -$3.13 | -13.82% | $15.41M | $52.70M | $52.28M | -0.79% | Get Alert |
09/05/2023 | PM | ASND | Q2 | -$1.56 | -$2.68 | -$2.35 | 1231.34% | $6.57M | $41.73M | $51.66M | 2378.38% | Get Alert |
04/27/2023 | PM | ASND | Q1 | -$2.48 | — | -$2.13 | — | $7.67M | — | $36.05M | — | Get Alert |
02/16/2023 | PM | ASND | Q4 | -$2.14 | — | -$3.78 | — | $5.60M | — | $23.37M | — | Get Alert |
11/02/2022 | PM | ASND | Q3 | -$1.73 | -$2.48 | -$3.05 | -22.98% | $1.31M | — | $15.41M | — | Get Alert |
08/10/2022 | PM | ASND | Q2 | -$3.01 | -$2.17 | -$1.56 | 28.11% | $1.23M | $5.92M | $6.57M | 10.90% | Get Alert |
05/11/2022 | PM | ASND | Q1 | -$1.41 | — | -$2.48 | — | $899.60K | — | $7.67M | — | Get Alert |
03/02/2022 | PM | ASND | Q4 | -$3.15 | -$2.63 | -$2.14 | 18.63% | $637.88K | $2.98M | $5.60M | 87.95% | Get Alert |
11/10/2021 | PM | ASND | Q3 | -$2.70 | — | -$1.73 | — | $3.22B | — | $1.31M | — | Get Alert |
08/25/2021 | PM | ASND | Q2 | -$2.17 | -$2.75 | -$3.01 | -9.45% | $1.58M | $1.46M | $1.23M | -15.68% | Get Alert |
05/27/2021 | PM | ASND | Q1 | -$1.46 | -$2.08 | -$1.41 | 32.21% | $2.45M | $2.30M | $899.60K | -60.89% | Get Alert |
03/10/2021 | PM | ASND | Q4 | -$1.89 | -$1.83 | -$3.15 | -72.13% | $2.78M | $1.99M | $637.88K | -67.95% | Get Alert |
11/11/2020 | PM | ASND | Q3 | -$0.58 | -$1.86 | -$2.70 | -45.16% | $2.24M | $1.66M | $3.22M | 94.10% | Get Alert |
08/27/2020 | PM | ASND | Q2 | -$1.39 | -$1.70 | -$2.17 | -27.65% | $3.56M | $2.53M | $1.58M | -37.51% | Get Alert |
05/19/2020 | PM | ASND | Q1 | -$1.38 | -$1.50 | -$1.46 | 2.67% | $6.01M | $2.07M | $2.45M | 18.55% | Get Alert |
04/01/2020 | PM | ASND | Q4 | -$0.85 | -$1.19 | -$1.89 | -58.82% | $11.78M | $1.25M | $2.78M | 122.64% | Get Alert |
11/18/2019 | PM | ASND | Q3 | -$0.92 | — | -$0.58 | — | $22.80K | — | $2.44M | — | Get Alert |
Ascendis Pharma (ASND) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 7, 2024 for Q4.
The Actual EPS was $-1.66, which beat the estimate of $-2.15.
The Actual Revenue was $148.2M, which beat the estimate of $97M.
Browse earnings estimates, EPS, and revenue on all stocks.